01 1Amphastar Pharmaceuticals
01 1FLUTICASONE PROPIONATE, USP
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-10-02
Pay. Date : 2015-07-10
DMF Number : 29454
Submission : 2015-06-29
Status : Active
Type : II
20
Amphastar Nanjing Pharmaceuticals Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FLUTICASONE PROPIONATE, USP, with a corresponding US DMF Number 29454.
Remarkably, this DMF maintains an Active status since its submission on June 29, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 02, 2015, and payment made on July 10, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
